CABALETTA BIO, INC. Earnings Per Share (Basic)
CABALETTA BIO, INC. (CABA) reported Earnings Per Share (Basic) of -$0.34 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-13
- CABALETTA BIO, INC. earnings per share, basic for the quarter ending 2026-06-30 was -$0.34.
- CABALETTA BIO, INC. earnings per share, basic for the quarter ending 2026-03-31 was -$0.39.
- CABALETTA BIO, INC. earnings per share, basic for the quarter ending 2025-09-30 was -$0.44.
- CABALETTA BIO, INC. earnings per share, basic for the quarter ending 2025-06-30 was -$0.73.
- CABALETTA BIO, INC. earnings per share, basic for fiscal 2025 was -$2.10.
- CABALETTA BIO, INC. earnings per share, basic for fiscal 2024 was -$2.34.
- CABALETTA BIO, INC. earnings per share, basic for fiscal 2023 was -$1.65.
- CABALETTA BIO, INC. earnings per share, basic for fiscal 2022 was -$1.81.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$0.34 10-Q · filed 2026-08-13 | -$0.72 10-Q · filed 2026-08-13 | ||
| 2026-03-31 | -$0.39 10-Q · filed 2026-05-14 | |||
| 2025-12-31 | -$2.10 10-K · filed 2026-03-23 | |||
| 2025-09-30 | -$0.44 10-Q · filed 2025-11-10 | -$1.75 10-Q · filed 2025-11-10 | ||
| 2025-06-30 | -$0.73 10-Q · filed 2026-08-13 | -$1.44 10-Q · filed 2026-08-13 | ||
| 2025-03-31 | -$0.71 10-Q · filed 2026-05-14 | |||
| 2024-12-31 | -$2.34 10-K · filed 2026-03-23 | |||
| 2024-09-30 | -$0.62 10-Q · filed 2025-11-10 | -$1.69 10-Q · filed 2025-11-10 | ||
| 2024-06-30 | -$0.56 10-Q · filed 2025-08-07 | -$1.07 10-Q · filed 2025-08-07 | ||
| 2024-03-31 | -$0.51 10-Q · filed 2025-05-15 | |||
| 2023-12-31 | -$1.65 10-K · filed 2025-03-31 | |||
| 2023-09-30 | -$0.37 10-Q · filed 2024-11-14 | -$1.18 10-Q · filed 2024-11-14 | ||
| 2023-06-30 | -$0.37 10-Q · filed 2024-08-08 | -$0.81 10-Q · filed 2024-08-08 | ||
| 2023-03-31 | -$0.45 10-Q · filed 2024-05-15 | |||
| 2022-12-31 | -$1.81 10-K · filed 2024-03-21 | |||
| 2022-09-30 | -$0.39 10-Q · filed 2023-11-09 | -$1.29 10-Q · filed 2023-11-09 | ||
| 2022-06-30 | -$0.45 10-Q · filed 2023-08-10 | -$0.89 10-Q · filed 2023-08-10 | ||
| 2022-03-31 | -$0.45 10-Q · filed 2023-05-11 | |||
| 2021-12-31 | -$1.80 10-K · filed 2023-03-16 | |||
| 2021-09-30 | -$0.45 10-Q · filed 2022-11-10 | -$1.31 10-Q · filed 2022-11-10 | ||
| 2021-06-30 | -$0.45 10-Q · filed 2022-08-11 | -$0.86 10-Q · filed 2022-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |